Health Catalyst (HCAT - Free Report) reported $75.08 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 8.6%. EPS of $0.02 for the same period compares to -$0.05 a year ago.
The reported revenue represents a surprise of +1.92% over the Zacks Consensus Estimate of $73.67 million. With the consensus EPS estimate being -$0.01, the EPS surprise was +300.00%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Professional services: $27.98 million versus $27.71 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +14.2% change.
- Revenue- Technology: $47.10 million versus the seven-analyst average estimate of $46.05 million. The reported number represents a year-over-year change of +5.5%.
- Adjusted Gross Profit- Professional Services: $3.31 million versus $3.20 million estimated by six analysts on average.
- Adjusted Gross Profit- Technology: $31.39 million compared to the $31.43 million average estimate based on six analysts.
View all Key Company Metrics for Health Catalyst here>>>Shares of Health Catalyst have returned -3.7% over the past month versus the Zacks S&P 500 composite's +3.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Top 5 ChatGPT Stocks Revealed
Zacks Senior Stock Strategist, Kevin Cook names 5 hand-picked stocks with sky-high growth potential in a brilliant sector of Artificial Intelligence. By 2030, the AI industry is predicted to have an internet and iPhone-scale economic impact of $15.7 Trillion.
Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests. As one of the selected companies puts it, “Automation frees people from the mundane so they can accomplish the miraculous.”
Download Free ChatGPT Stock Report Right Now >>
Health Catalyst (HCAT - Free Report) reported $75.08 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 8.6%. EPS of $0.02 for the same period compares to -$0.05 a year ago.
The reported revenue represents a surprise of +1.92% over the Zacks Consensus Estimate of $73.67 million. With the consensus EPS estimate being -$0.01, the EPS surprise was +300.00%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Professional services: $27.98 million versus $27.71 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +14.2% change.
- Revenue- Technology: $47.10 million versus the seven-analyst average estimate of $46.05 million. The reported number represents a year-over-year change of +5.5%.
- Adjusted Gross Profit- Professional Services: $3.31 million versus $3.20 million estimated by six analysts on average.
- Adjusted Gross Profit- Technology: $31.39 million compared to the $31.43 million average estimate based on six analysts.
View all Key Company Metrics for Health Catalyst here>>>Shares of Health Catalyst have returned -3.7% over the past month versus the Zacks S&P 500 composite's +3.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Top 5 ChatGPT Stocks Revealed
Zacks Senior Stock Strategist, Kevin Cook names 5 hand-picked stocks with sky-high growth potential in a brilliant sector of Artificial Intelligence. By 2030, the AI industry is predicted to have an internet and iPhone-scale economic impact of $15.7 Trillion.
Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests. As one of the selected companies puts it, “Automation frees people from the mundane so they can accomplish the miraculous.”
Download Free ChatGPT Stock Report Right Now >>
Get the latest research report on HCAT - FREE